RESEARCH ARTICLE
An Overview of Cardiac Management in Neuromuscular Disease
Renee M. Hickey, John D. Cullen, George M. Sachs*
Article Information
Identifiers and Pagination:
Year: 2016Volume: 10
Issue: Suppl-1, M2
First Page: 82
Last Page: 88
Publisher ID: TOCMJ-10-82
DOI: 10.2174/1874192401610010082
Article History:
Received Date: 29/9/2015Revision Received Date: 08/10/2015
Acceptance Date: 25/11/2015
Electronic publication date: 27/05/2016
Collection year: 2016

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
Abstract
Muscular dystrophy and myasthenia gravis are two neuromuscular disorders that can involve significant cardiovascular complications. The frequency and severity of cardiac pathology varies widely among the muscular dystrophies. In some, it is nearly inevitable and requires regular evaluation. In others, assessment of cardiac function can be more symptom-driven. On-ly a minority of myasthenic patients manifest disease-related cardiovascular complications; however, their presentation can be rapidly progressive and life-threatening..